Schools report 20 COVID-19 cases in Wyandotte County

7 students, 13 staff test positive

The locations of schools where there are COVID-19 cases in Wyandotte County are shown on a map on the Unified Government’s COVID-19 Hub page. (From UG COVID-19 Hub page)

Wyandotte County schools have reported 20 COVID-19 cases, according to the Unified Government’s COVID-19 Hub page.

Of the 20, seven were student cases and the rest were staff cases, according to the map.

The Turner school district reported six student cases, and the Piper school district reported one student case, according to the map’s information.

The Kansas City, Kansas, school district reported 13 staff cases and no student cases, the map showed.

A schools map on the webpage showed that there were COVID-19 cases at these school district locations:

In the Kansas City, Kansas, Public Schools:

Rosedale Middle School, 2 staff cases reported, 3600 Springfield St., Kansas City, Kansas.
Carl B. Bruce Middle School, 3 staff cases reported, 2112 N. 18th St., Kansas City, Kansas.
Central Middle School, 1 staff case, 925 Ivandale St., Kansas City, Kansas.
McKinley Elementary School, 1 staff case, 1301 Armstrong Ave.
Frances Willard Elementary School, 1 staff case, 3400 Orville Ave., Kansas City, Kansas.
Eugene Ware Elementary School, 1 staff case, 4820 Oakland Ave., Kansas City, Kansas.
Welborn Elementary, 1 staff case, 5200 Leavenworth Road, Kansas City, Kansas.
Schlagle High School, 1 staff case, 2214 N. 59th St., Kansas City, Kansas.
Kennedy Elementary School, 1 staff case, 2600 N. 72nd St., Kansas City, Kansas.
Washington High School, 1 staff case, 7340 Leavenworth Road, Kansas City, Kansas.

In the Turner Public Schools:

Turner High School, 2 student cases, 2211 S. 55th, Kansas City, Kansas.
Turner Middle School, 2 student caes, 1312 S. 55th St., Kansas City, Kansas.
Turner Elementary School, 1 student case, 1800 S. 55th St.
Turner Sixth Grade Academy, 1 student case, 6425 Riverview Ave. Kansas City, Kanas.

In the Piper Public Schools:

Piper Middle School, 1 student case, 4420 N. 107th St., Kansas City, Kansas.

COVID-19 school outbreaks in Wyandotte County were shown on the Unified Government Health Department COVID-19 Hub page at

Police notes

Bullets hit garage on North 44th

A garage was hit by bullets about 3:08 a.m. Sept. 21 in the 2300 block of North 44th, according to a social media post by the Kansas City, Kansas, Police Department.

Several shell casings were discovered. There were no injuries, according to the report.

Commercial burglary reported on State Avenue

A commercial burglary was reported at 6:20 a.m. Sept. 21 in the 7700 block of State Avenue, according to a social media post by the Kansas City, Kansas, Police Department.

Officers discovered that a door had been forced open, the report stated. Owners said several items had been taken, according to the report.

Shooting into vehicle reported on Delavan

A shooting into an occupied vehicle was reported at 10:30 p.m. Sept. 21 in the 2600 block of Delavan, according to a social media post by the Kansas City, Kansas, Police Department.

The victim said he was driving when an unknown suspect shot and struck the vehicle, according to the report.

The suspect thought that the victim had been shooting at the suspect, and said that is why the suspect returned fire, according to the report. There were no injuries, police stated.

KUMC to participate in COVID-19 clinical trial for outpatient treatment

A new trial will test antibodies on volunteer outpatients who have COVID-19, according to officials.

Dr. Mario Castro, vice chair for clinical and translational research at the University of Kansas Medical Center, said participants in the trial would receive a one-time treatment with an intravenous infusion for 60 minutes. ACTIV-2 is the name of the clinical trial. KUMC is one of 40 participating sites in the trial.

The trial allows the doctors to introduce different agents as they become available, according to Dr. Castro. The first one will be a monoclonal antibody from Eli Lilly and Co. Antibodies are made from immune cells and fight infections.

The drug was manufactured in a lab from antibodies isolated from a patient who had a COVID-19 infection, he said at a news conference on Tuesday morning at the KU Health System. The antibodies were studied, and monoclonal antibodies were developed from it, he said. It targets the spike protein on COVID-19, he added.

“The early phase 2 trials look very promising,” he said. This trial will enroll around the country, and will help determine how safe and efficacious it is, he said.

It is not active treatment, but an opportunity to participate in a study, Dr. Castro said. Some of the study participants will get a placebo, he added.

Those who are infected with SARS-CoV-2 and have mild-to-moderate COVID-19 not requiring hospitalization are eligible for the trial. Those who want to participate in the trial may call 913-588-4022 for more information, he said.

The trial is sponsored by the National Institutes of Health, he said.

KU earlier was participating in an Astra-Zeneca vaccine trial that was put on hold to investigate a patient’s reaction to it in the United Kingdom, he said. The trial resumed in the UK but the case is still under review in the United States, he said.

The KU doctors’ news conference is online at